Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Beom Seok Jeon"'
Autor:
Jae Meen Lee, Sun Ha Paek, Hye Ran Park, Kang Hee Lee, Chae Won Shin, Hye Young Park, Hee Pyoung Park, Dong Gyu Kim, Beom Seok Jeon
Publikováno v:
Korean Journal of Critical Care Medicine, Vol 31, Iss 1, Pp 34-38 (2016)
Neuroleptic malignant syndrome (NMS) is a rare but potentially lethal outcome caused by sudden discontinuation or dose reduction of dopaminergic agents. We report an extremely rare case of NMS after deep brain stimulation (DBS) surgery in a cerebral
Externí odkaz:
https://doaj.org/article/1ef204d36fbc44cf87eb657ec0cfe45c
Autor:
Jae-Hyeok Lee, Jongkyu Park, Ho-Sung Ryu, Hyeyoung Park, Young Eun Kim, Jin Yong Hong, Sang Ook Nam, Young-Hee Sung, Seung-Hwan Lee, Jee-Young Lee, Myung Jun Lee, Tae-Hyoung Kim, Chul Hyoung Lyoo, Sun Ju Chung, Seong Beom Koh, Phil Hyu Lee, Jin Whan Cho, Mee Young Park, Yun Joong Kim, Young H. Sohn, Beom Seok Jeon, Myung Sik Lee
Publikováno v:
Journal of Movement Disorders, Vol 9, Iss 1, Pp 20-27 (2016)
Objective Neurodegeneration with brain iron accumulation (NBIA) represents a group of inherited movement disorders characterized by iron accumulation in the basal ganglia. Recent advances have included the identification of new causative genes and hi
Externí odkaz:
https://doaj.org/article/524027f3f1a442e69f4564476713d2ea
Autor:
Jee-Young Lee, Beom Seok Jeon
Publikováno v:
Journal of Movement Disorders, Vol 7, Iss 2, Pp 67-76 (2014)
Impulse control disorders (ICD) in Parkinson’s disease (PD) are a disabling non-motor symptom with frequencies of 13–35% among patients receiving dopamine replacement therapy. ICD in PD is strongly associated with dopaminergic drug use, especiall
Externí odkaz:
https://doaj.org/article/c84658f796c14f288b36a94e726fa8df
Autor:
Hang Rai Kim, Jee-Young Lee, Yu Kyeong Kim, Hyeyoung Park, Han-Joon Kim, Young-Je Son, Beom Seok Jeon
Publikováno v:
Journal of Movement Disorders, Vol 8, Iss 3, Pp 141-143 (2015)
Externí odkaz:
https://doaj.org/article/485996b5d4474a46908ecc30cce092b6
Autor:
Hye Ran Park, Jae Meen Lee, Gwanhee Ehm, Hui-Jun Yang, In Ho Song, Yong Hoon Lim, Mi-Ryoung Kim, Keyoung Ran Kim, Woong-Woo Lee, Young Eun Kim, Jae Ha Hwang, Chae Won Shin, Hyeyoung Park, Jin Wook Kim, Han-Joon Kim, Cheolyoung Kim, Dong Gyu Kim, Beom Seok Jeon, Sun Ha Paek
Publikováno v:
PLoS ONE, Vol 11, Iss 1, p e0146644 (2016)
BACKGROUND:GPi (Internal globus pallidus) DBS (deep brain stimulation) is recognized as a safe, reliable, reversible and adjustable treatment in patients with medically refractory dystonia. OBJECTIVES:This report describes the long-term clinical outc
Externí odkaz:
https://doaj.org/article/0d9f8144d3b648239213a1b92d835179
Publikováno v:
Journal of Movement Disorders, Vol 2, Iss 2, Pp 91-94 (2009)
X-linked adrenoleukodystrophy (X-ALD) is a hereditary neurological disorder affecting the nervous system and adrenal cortex. The phenotype of X-ALD ranges from the rapidly progressive cerebral form to milder adrenomyeloneuropathy. However, cerebellar
Externí odkaz:
https://doaj.org/article/4ce890ceeefb4e41a9cad747db408c25
Autor:
Jung Hwan Shin, Hyeyoung Park, Gwan Hee Ehm, Woong Woo Lee, Ji Young Yun, Young Eun Kim, Jee-Young Lee, Han-Joon Kim, Jong-Min Kim, Beom Seok Jeon, Sung-Sup Park
Publikováno v:
PLoS ONE, Vol 10, Iss 8, p e0135275 (2015)
SCA17 is an autosomal dominant cerebellar ataxia with expansion of the CAG/CAA trinucleotide repeats in the TATA-binding protein (TBP) gene. SCA17 can have various clinical presentations including parkinsonism, ataxia, chorea and dystonia. SCA17 is d
Externí odkaz:
https://doaj.org/article/d9f517ca81124d41a9c77f8127713174
Publikováno v:
PLoS ONE, Vol 9, Iss 3, p e91906 (2014)
BACKGROUND: Classical and data-driven classifications of Parkinson's disease (PD) are based primarily on motor symptoms, with little attention being paid to the clustering of nonmotor manifestations. METHODS: Clinical data on demographic, motor and n
Externí odkaz:
https://doaj.org/article/d28dc8d3ee5f443a8e7f80550289e7a4
Autor:
Sun Ju, Chung, Jong-Min, Kim, Jae Woo, Kim, Beom Seok, Jeon, Pritibha, Singh, Stephan, Thierfelder, Junji, Ikeda, Lars, Bauer, Mark, Fisher
Publikováno v:
Expert opinion on pharmacotherapy. 16(7)
Investigate safety, feasibility and efficacy of switching therapy in patients with advanced-stage Parkinson's disease (PD) inadequately controlled with pramipexole (≤ 3.5 mg/day) or ropinirole (≤ 14 mg/day) to rotigotine transdermal system (≤ 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::825e01e9ea47d755eee4b806695c224f
https://pubmed.ncbi.nlm.nih.gov/25846031
https://pubmed.ncbi.nlm.nih.gov/25846031
Autor:
Sun Ju, Chung, Joanna M, Biernacka, Sebastian M, Armasu, Kari, Anderson, Roberta, Frigerio, Jan O, Aasly, Grazia, Annesi, Anna Rita, Bentivoglio, Laura, Brighina, Marie-Christine, Chartier-Harlin, Stefano, Goldwurm, Georgios, Hadjigeorgiou, Barbara, Jasinska-Myga, Beom Seok, Jeon, Yun Joong, Kim, Rejko, Krüger, Suzanne, Lesage, Katerina, Markopoulou, George, Mellick, Karen E, Morrison, Andreas, Puschmann, Eng-King, Tan, David, Crosiers, Jessie, Theuns, Christine, Van Broeckhoven, Karin, Wirdefeldt, Zbigniew K, Wszolek, Alexis, Elbaz, Demetrius M, Maraganore
To determine whether α-synuclein dinucleotide repeat (REP1) genotypes are associated with survival in Parkinson's disease (PD).Investigators from the Genetic Epidemiology of Parkinson's Disease Consortium provided REP1 genotypes and baseline and fol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::ee2d44f3d06eaef3cd8640d104e7edc8
http://hdl.handle.net/10807/64280
http://hdl.handle.net/10807/64280
